Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | Belfast Health & Social Care Trust |
| Main Category: | — |
| Procurement Method: | Direct award |
| Method Rationale: | These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement. |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 7 July 2026 |
| Application Deadline: |
All 3 notices for this procurement, oldest first.
MIFAMURTIDE 4MG POWDER FOR SUSPENSION FOR INFUSION
MIFAMURTIDE 4MG POWDER FOR SUSPENSION FOR INFUSION
MIFAMURTIDE 4MG POWDER FOR SUSPENSION FOR INFUSION
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award status: | Active |
Procurement of MIFAMURTIDE 4MG POWDER FOR SUSPENSION FOR INFUSION
Published contracts in the last 12 months
189
total contracts
£110.4m
total value
£13,803,922
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| — |
| Procurement ID (OCID): | ocds-h6vhtk-06b67e |
| Notice Reference: | 063438-2026 |